Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 5, Pages 690
Publisher
MDPI AG
Online
2019-05-17
DOI
10.3390/cancers11050690
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update
- (2019) Priyancy G. Jain et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
- (2019) Sofia Genta et al. Current Oncology Reports
- A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
- (2019) Peter Hajek et al. NEW ENGLAND JOURNAL OF MEDICINE
- The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients’ sex
- (2019) Shixiang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts
- (2019) Paul M. Putora et al. RADIOTHERAPY AND ONCOLOGY
- Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
- (2019) Wei-Di Yu et al. CANCER LETTERS
- Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism
- (2019) Katarzyna Zabłocka-Słowińska et al. PLoS One
- Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
- (2018) D E Gerber et al. ANNALS OF ONCOLOGY
- Prevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer
- (2018) GOUJI TOYOKAWA et al. ANTICANCER RESEARCH
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by IncreasingNOTCH1Expression and Targeting Tumor-Initiating Cells
- (2018) Sarmishtha De et al. CANCER RESEARCH
- Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer
- (2018) Lydia Meder et al. CANCER RESEARCH
- Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors
- (2018) Mahalakshmi Ramadoss et al. DRUG DISCOVERY TODAY
- Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
- (2018) M. Catherine Pietanza et al. JOURNAL OF CLINICAL ONCOLOGY
- Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models
- (2018) Lin Yu et al. JOURNAL OF DRUG TARGETING
- Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer
- (2018) Kentaro Tanaka et al. LUNG CANCER
- Higher Lung Cancer Incidence in Young Women Than Young Men in the United States
- (2018) Ahmedin Jemal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models
- (2018) Denise L. Crossland et al. ONCOGENE
- NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
- (2018) Khaled Seidi et al. ONCOGENE
- ALK-rearranged adenocarcinoma transformed to small-cell lung cancer: a new entity with specific prognosis and treatment?
- (2018) Charbel Hobeika et al. Personalized Medicine
- EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
- (2018) Hongyang Lu et al. OncoTargets and Therapy
- The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
- (2018) David M. Goldenberg et al. Oncotarget
- Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: Results from the exploratory, controlled, randomized, international phase 2 IMPULSE study
- (2018) M Thomas et al. ANNALS OF ONCOLOGY
- Results of the first-in-human study of ABBV-075 (mivebresib), a pan-inhibitor of bromodomain (BD) and extra terminal (BET) proteins, in patients (pts) with relapsed/refractory (R/R) solid tumors.
- (2018) Sarina Anne Piha-Paul et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.
- (2018) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment
- (2018) Ippokratis Messaritakis et al. LUNG CANCER
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
- (2018) Vanesa Gregorc et al. ONCOLOGIST
- Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
- (2018) Torsten Kessler et al. Translational Oncology
- Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate
- (2018) Bilal H. Lashari et al. Drugs in research & development
- Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition
- (2018) Deshui Jia et al. Cancer Discovery
- Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer
- (2018) Yanis Boumber Journal of Thoracic Disease
- LBA5Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
- (2018) M Reck et al. ANNALS OF ONCOLOGY
- A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors
- (2018) Florence Atrafi et al. CLINICAL CANCER RESEARCH
- A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
- (2018) David C. Smith et al. INVESTIGATIONAL NEW DRUGS
- Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study
- (2018) Taofeek K. Owonikoko et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
- (2018) Nicolas Marcoux et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
- (2018) Gregory P. Kalemkerian et al. Journal of the National Comprehensive Cancer Network
- Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis
- (2018) Hibiki Udagawa et al. LUNG CANCER
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin
- (2018) E. Gezelius et al. PLoS One
- Cells Lacking the RB1 Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for Survival
- (2018) Matthew G. Oser et al. Cancer Discovery
- Overcoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib
- (2018) Kejing Tang et al. Thoracic Cancer
- Optimal timing of thoracic radiotherapy in limited stage small cell lung cancer (SCLC) with daily fractionation: A brief report
- (2018) Shaakir Hasan et al. RADIOTHERAPY AND ONCOLOGY
- Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
- (2018) Neal Ready et al. Journal of Thoracic Oncology
- Lenalidomide in the treatment of chronic lymphocytic leukemia
- (2017) Gilad Itchaki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular alterations of neuroendocrine tumours of the lung
- (2017) Giulio Rossi et al. HISTOPATHOLOGY
- Angiogenesis Inhibitors in NSCLC
- (2017) Anna Manzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors
- (2017) Tomohiro Nishina et al. INVESTIGATIONAL NEW DRUGS
- Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
- (2017) Marcello Tiseo et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
- (2017) Michael J. Seckl et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy of Advanced Non–Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
- (2017) Rebecca Suk Heist et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2 : CALGB 151111 (Alliance)
- (2017) Arnaud Augert et al. Journal of Thoracic Oncology
- OA05.05 Randomized Phase 2 Study: Alisertib (MLN8237) or Placebo + Paclitaxel as Second-Line Therapy for Small-Cell Lung Cancer (SCLC)
- (2017) Taofeek Owonikoko et al. Journal of Thoracic Oncology
- Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer
- (2017) Alberto Ballestrero et al. Journal of Translational Medicine
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
- (2017) Charles M Rudin et al. LANCET ONCOLOGY
- Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer
- (2017) Martin Reck et al. LUNG CANCER
- CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer
- (2017) Lars Henning Schmidt et al. LUNG CANCER
- Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors
- (2017) Lloyd T. Lam et al. MOLECULAR CANCER THERAPEUTICS
- Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma
- (2017) Yanqing Yang et al. Molecular Medicine Reports
- Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer
- (2017) Jing Shan Lim et al. NATURE
- Unravelling the biology of SCLC: implications for therapy
- (2017) Joshua K. Sabari et al. Nature Reviews Clinical Oncology
- The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer
- (2017) A Szczepny et al. ONCOGENE
- Potential therapeutic impact of CD13 expression in non-small cell lung cancer
- (2017) Lars Henning Schmidt et al. PLoS One
- Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
- (2017) Akane Inoue-Yamauchi et al. Nature Communications
- Significantly mutated genes and regulatory pathways in SCLC—a meta-analysis
- (2017) Varsha Sundaresan et al. Cancer Genetics
- Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models
- (2017) Lin Yu et al. Oncotarget
- Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing
- (2017) Masaoki Ito et al. Oncotarget
- JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer
- (2017) Huogang Wang et al. Oncotarget
- Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)
- (2016) Chandra P. Belani et al. CANCER
- A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113
- (2016) Rachel E. Sanborn et al. CANCER
- A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors
- (2016) Emiliano Calvo et al. CLINICAL CANCER RESEARCH
- A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer
- (2016) A. V. Gaponova et al. CLINICAL CANCER RESEARCH
- PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer
- (2016) Benjamin H. Lok et al. CLINICAL CANCER RESEARCH
- Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a ‘chemosensitive’ relapse: A single-arm phase II study (EORTC-08061)
- (2016) Fatma Abdelraouf et al. EUROPEAN JOURNAL OF CANCER
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Naiyer A. Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
- (2016) M. Catherine Pietanza et al. LUNG CANCER
- A phase II study of nintedanib in patients with relapsed small cell lung cancer
- (2016) Ji-Youn Han et al. LUNG CANCER
- Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC
- (2016) Danielle S. Potter et al. MOLECULAR CANCER THERAPEUTICS
- Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo
- (2016) B. A. Helfrich et al. MOLECULAR CANCER THERAPEUTICS
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
- (2016) Alberto A. Chiappori et al. ONCOLOGIST
- Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
- (2016) Kaja Skjefstad et al. STEROIDS
- 125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
- (2016) Peng-Hui Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells
- (2016) Fuyumi Kato et al. Oncotarget
- Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
- (2016) Young Kwang Chae et al. Oncotarget
- Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction
- (2016) Janine Stucke-Ring et al. Oncotarget
- Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
- (2016) Nadine S. Jahchan et al. Cell Reports
- Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis
- (2016) Mingming Hu et al. PLoS One
- Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer
- (2015) Oleg Gladkov et al. ANTI-CANCER DRUGS
- Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer
- (2015) Wataru Nakajima et al. CANCER BIOLOGY & THERAPY
- Targeted therapy in cancer
- (2015) Apostolia-Maria Tsimberidou CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PD-L1 expression in small cell neuroendocrine carcinomas
- (2015) Anne M. Schultheis et al. EUROPEAN JOURNAL OF CANCER
- Increased insulin-like growth factor 1 receptor (IGF1R) expression in small cell lung cancer and the effect of inhibition of IGF1R expression by RNAi on growth of human small cell lung cancer NCI-H446 cell
- (2015) Zhigang Wang et al. GROWTH FACTORS
- Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer
- (2015) Shinji Takeuchi et al. INTERNATIONAL JOURNAL OF CANCER
- Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma
- (2015) Yuki Matsumura et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)
- (2015) Neal E. Ready et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
- (2015) Bohuslav Melichar et al. LANCET ONCOLOGY
- Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR
- (2015) Caroline Brand et al. MOLECULAR PHARMACEUTICS
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
- (2015) J T Poirier et al. ONCOGENE
- Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer
- (2015) Hongxin Cao et al. PLoS One
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
- (2015) Laura R. Saunders et al. Science Translational Medicine
- Novel and emerging targeted-based cancer therapy agents and methods
- (2015) Mohammad Hojjat-Farsangi TUMOR BIOLOGY
- RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
- (2015) Matthew J. Niederst et al. Nature Communications
- Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
- (2014) J.- C. Soria et al. ANNALS OF ONCOLOGY
- Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer
- (2014) G. V. Scagliotti et al. ANNALS OF ONCOLOGY
- Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer
- (2014) E. E. Gardner et al. CANCER RESEARCH
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Fibroblast Growth Factor Receptor 1 in Small-Cell Lung Cancer
- (2014) Anish Thomas et al. Journal of Thoracic Oncology
- A Randomized, Phase 2 Trial of Docetaxel with or without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Relapsed or Metastatic Non–Small-Cell Lung Cancer
- (2014) Benjamin Levy et al. Journal of Thoracic Oncology
- Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients
- (2014) Paola Bordi et al. LUNG CANCER
- Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models
- (2014) Kathleen R Whiteman et al. mAbs
- Many players in BCL-2 family affairs
- (2014) Tudor Moldoveanu et al. TRENDS IN BIOCHEMICAL SCIENCES
- A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer
- (2013) B. Besse et al. ANNALS OF ONCOLOGY
- A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours
- (2013) D W Bowles et al. BRITISH JOURNAL OF CANCER
- A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer
- (2013) J M Sun et al. BRITISH JOURNAL OF CANCER
- Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer
- (2013) Reika Iwakawa et al. GENES CHROMOSOMES & CANCER
- Anticancer Therapy by Tumor Vessel Infarction with Polyethylene Glycol Conjugated Retargeted Tissue Factor
- (2013) Christian Schwöppe et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer
- (2013) Peter M. Ellis et al. Journal of Thoracic Oncology
- Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer
- (2013) Anne M Schultheis et al. MODERN PATHOLOGY
- IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy
- (2013) C. Ferte et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms underlying RB protein function
- (2013) Frederick A. Dick et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer
- (2013) Bradley P. Coe et al. PLoS One
- Mechanisms of Action of Bcl-2 Family Proteins
- (2013) A. Shamas-Din et al. Cold Spring Harbor Perspectives in Biology
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF- B Activity
- (2012) T. Kuramoto et al. MOLECULAR CANCER THERAPEUTICS
- MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis In Vivo
- (2012) D. W. Jenkins et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment
- (2012) L. Guzman-Rojas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
- (2012) Lauren Averett Byers et al. Cancer Discovery
- A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer
- (2011) Joaquim Calbo et al. CANCER CELL
- Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
- (2011) Kate D. Sutherland et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Curaxins: A New Family of Non-genotoxic Multitargeted Anticancer Agents
- (2011) Valeria Di Bussolo et al. ChemMedChem
- Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment
- (2011) Paul DeRose et al. Immunotherapy
- A crucial requirement for Hedgehog signaling in small cell lung cancer
- (2011) Kwon-Sik Park et al. NATURE MEDICINE
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Aminopeptidase N (CD13) as a target for cancer chemotherapy
- (2010) Malin Wickström et al. CANCER SCIENCE
- Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer
- (2010) A. Tarhini et al. CLINICAL CANCER RESEARCH
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer
- (2010) Alan Sandler et al. Journal of Thoracic Oncology
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tissue-factor fusion proteins induce occlusion of tumor vessels
- (2010) Christian Schwöppe et al. THROMBOSIS RESEARCH
- Flipping the wound that doesn't heal: the upside of coagulation in cancer
- (2009) B. A. Teicher BLOOD
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2009) Siow Ming Lee et al. JNCI-Journal of the National Cancer Institute
- Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy
- (2009) Seong Hyun Jeong et al. LUNG CANCER
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
- (2008) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started